How many cisplatin administration protocols does your department use?

Alastair Peter Greystoke, Duncan I. Jodrell, M. Cheung, I Rivans, Melanie J Mackean
Published 2010 in European journal of cancer care

Abstract

The introduction, 30 years ago, of the co-administration of appropriate hydration and ensuring a diuresis occurs during the administration of cisplatin was important in its development, allowing clinically significant doses to be given with acceptable rates of toxicity. The clinical usage of cisplatin has increased and hydration protocols have been amended… (More)

DOI: 10.1111/j.1365-2354.2007.00908.x

Topics

2 Figures and Tables

Cited By

Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.

Emiko Sakaida, Shunichiro Iwasawa, +7 authors Yuichi Takiguchi
Japanese journal of clinical oncology
2016

Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.

Antonio Macciò, Clelia Madeddu
Expert opinion on pharmacotherapy
2013

References

Sort by:

Showing 1-10 of 75 references

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

D S Alberts, S Green, +7 authors C J Jolles
Journal of clinical oncology : official journal…
1992

E. Reed
Chabner B.A. & Longo D.L.),
2006

[Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol].

Guillaume Saint-Lorant, Jeannick Madelaine, Marie-Pierre Galais, Lobbedez Thierry, Valérie Chédru-Legros
Therapie
2005

A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil.

T R Evans, C L Harper, I G Beveridge, R Wastnage, J L Mansi
European journal of cancer
1995

Phase I trial of escalating doses of cisplatin in hypertonic saline.

D Bajorin, G J Bosl, R Fein
Journal of clinical oncology : official journal…
1987

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.

A B Campbell, S M Kalman, C Jacobs
Cancer treatment reports
1983

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

D M Hayes, E Cvitkovic, R B Golbey, E Scheiner, L Helson, I H Krakoff
Cancer
1977

Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.

D J Higby, H J Wallace, D J Albert, J F Holland
Cancer
1974

Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin

H Lajer, H Bundgaard, N H Secher, H H Hansen, K Kjeldsen, G Daugaard
British Journal of Cancer
2003

Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

David J. Stewart, Corinne S. Dulberg, Nadia Z. Mikhael, M. Deidre Redmond, Vital A. J. Montpetit, Rakesh Goel
Cancer Chemotherapy and Pharmacology
1997

How many cisplatin administration protocols does your department use?

Abstract

Topics

2 Figures and Tables

Cited By

Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.

Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.

References

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

Cancer chemotherapy & biotherapy. In: Principles and Practices, 4th edn (eds

[Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol].

A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil.

Phase I trial of escalating doses of cisplatin in hypertonic saline.

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.

Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin

Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

Slides referencing similar topics

How many cisplatin administration protocols does your department use?

Abstract

Topics

2 Figures and Tables

Cited By

Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.

Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.

References

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

Cancer chemotherapy & biotherapy. In: Principles and Practices, 4th edn (eds

[Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol].

A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil.

Phase I trial of escalating doses of cisplatin in hypertonic saline.

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.

Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin

Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

Similar Papers

Slides referencing similar topics